COVID-19 Impact on Global Prostate-specific Antigen (PSA) Testing Market Size, Status and Forecast 2020-2026

COVID-19 Impact on Global Prostate-specific Antigen (PSA) Testing Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Prostate-specific Antigen (PSA) Testing Revenue
1.4 Market Analysis by Type
1.4.1 Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 CLIA Method
1.4.3 ELISA Method
1.5 Market by Application
1.5.1 Global Prostate-specific Antigen (PSA) Testing Market Share by Application: 2020 VS 2026
1.5.2 Screening
1.5.3 Post-treatment Monitoring
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Prostate-specific Antigen (PSA) Testing Industry Impact
1.6.1 How the Covid-19 is Affecting the Prostate-specific Antigen (PSA) Testing Industry
1.6.1.1 Prostate-specific Antigen (PSA) Testing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Prostate-specific Antigen (PSA) Testing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Prostate-specific Antigen (PSA) Testing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Prostate-specific Antigen (PSA) Testing Market Perspective (2015-2026)
2.2 Prostate-specific Antigen (PSA) Testing Growth Trends by Regions
2.2.1 Prostate-specific Antigen (PSA) Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Prostate-specific Antigen (PSA) Testing Historic Market Share by Regions (2015-2020)
2.2.3 Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Prostate-specific Antigen (PSA) Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Prostate-specific Antigen (PSA) Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Prostate-specific Antigen (PSA) Testing Players by Market Size
3.1.1 Global Top Prostate-specific Antigen (PSA) Testing Players by Revenue (2015-2020)
3.1.2 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Prostate-specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio
3.2.1 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Prostate-specific Antigen (PSA) Testing Revenue in 2019
3.3 Prostate-specific Antigen (PSA) Testing Key Players Head office and Area Served
3.4 Key Players Prostate-specific Antigen (PSA) Testing Product Solution and Service
3.5 Date of Enter into Prostate-specific Antigen (PSA) Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Type (2015-2020)
4.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Type (2021-2026)
5 Prostate-specific Antigen (PSA) Testing Breakdown Data by Application (2015-2026)
5.1 Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
5.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Prostate-specific Antigen (PSA) Testing Market Size (2015-2020)
6.2 Prostate-specific Antigen (PSA) Testing Key Players in North America (2019-2020)
6.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020)
6.4 North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Prostate-specific Antigen (PSA) Testing Market Size (2015-2020)
7.2 Prostate-specific Antigen (PSA) Testing Key Players in Europe (2019-2020)
7.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020)
7.4 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
8 China
8.1 China Prostate-specific Antigen (PSA) Testing Market Size (2015-2020)
8.2 Prostate-specific Antigen (PSA) Testing Key Players in China (2019-2020)
8.3 China Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020)
8.4 China Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Prostate-specific Antigen (PSA) Testing Market Size (2015-2020)
9.2 Prostate-specific Antigen (PSA) Testing Key Players in Japan (2019-2020)
9.3 Japan Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020)
9.4 Japan Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size (2015-2020)
10.2 Prostate-specific Antigen (PSA) Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
11 India
11.1 India Prostate-specific Antigen (PSA) Testing Market Size (2015-2020)
11.2 Prostate-specific Antigen (PSA) Testing Key Players in India (2019-2020)
11.3 India Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020)
11.4 India Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Prostate-specific Antigen (PSA) Testing Market Size (2015-2020)
12.2 Prostate-specific Antigen (PSA) Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020)
12.4 Central & South America Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview and Its Total Revenue
13.1.3 Abbott Prostate-specific Antigen (PSA) Testing Introduction
13.1.4 Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Boston Scientific Corporation
13.2.1 Boston Scientific Corporation Company Details
13.2.2 Boston Scientific Corporation Business Overview and Its Total Revenue
13.2.3 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Introduction
13.2.4 Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
13.2.5 Boston Scientific Corporation Recent Development
13.3 Bayer AG
13.3.1 Bayer AG Company Details
13.3.2 Bayer AG Business Overview and Its Total Revenue
13.3.3 Bayer AG Prostate-specific Antigen (PSA) Testing Introduction
13.3.4 Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
13.3.5 Bayer AG Recent Development
13.4 Siemens Healthcare
13.4.1 Siemens Healthcare Company Details
13.4.2 Siemens Healthcare Business Overview and Its Total Revenue
13.4.3 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Introduction
13.4.4 Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
13.4.5 Siemens Healthcare Recent Development
13.5 DiaSorin
13.5.1 DiaSorin Company Details
13.5.2 DiaSorin Business Overview and Its Total Revenue
13.5.3 DiaSorin Prostate-specific Antigen (PSA) Testing Introduction
13.5.4 DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
13.5.5 DiaSorin Recent Development
13.6 Roche
13.6.1 Roche Company Details
13.6.2 Roche Business Overview and Its Total Revenue
13.6.3 Roche Prostate-specific Antigen (PSA) Testing Introduction
13.6.4 Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
13.6.5 Roche Recent Development
13.7 Beckman Coulter
13.7.1 Beckman Coulter Company Details
13.7.2 Beckman Coulter Business Overview and Its Total Revenue
13.7.3 Beckman Coulter Prostate-specific Antigen (PSA) Testing Introduction
13.7.4 Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
13.7.5 Beckman Coulter Recent Development
13.8 PerkinElmer
13.8.1 PerkinElmer Company Details
13.8.2 PerkinElmer Business Overview and Its Total Revenue
13.8.3 PerkinElmer Prostate-specific Antigen (PSA) Testing Introduction
13.8.4 PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
13.8.5 PerkinElmer Recent Development
13.9 Tosoh
13.9.1 Tosoh Company Details
13.9.2 Tosoh Business Overview and Its Total Revenue
13.9.3 Tosoh Prostate-specific Antigen (PSA) Testing Introduction
13.9.4 Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
13.9.5 Tosoh Recent Development
13.10 Ortho Clinical
13.10.1 Ortho Clinical Company Details
13.10.2 Ortho Clinical Business Overview and Its Total Revenue
13.10.3 Ortho Clinical Prostate-specific Antigen (PSA) Testing Introduction
13.10.4 Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
13.10.5 Ortho Clinical Recent Development
13.11 Fujirebio
10.11.1 Fujirebio Company Details
10.11.2 Fujirebio Business Overview and Its Total Revenue
10.11.3 Fujirebio Prostate-specific Antigen (PSA) Testing Introduction
10.11.4 Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
10.11.5 Fujirebio Recent Development
13.12 Mediwatch
10.12.1 Mediwatch Company Details
10.12.2 Mediwatch Business Overview and Its Total Revenue
10.12.3 Mediwatch Prostate-specific Antigen (PSA) Testing Introduction
10.12.4 Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
10.12.5 Mediwatch Recent Development
13.13 BodiTech
10.13.1 BodiTech Company Details
10.13.2 BodiTech Business Overview and Its Total Revenue
10.13.3 BodiTech Prostate-specific Antigen (PSA) Testing Introduction
10.13.4 BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
10.13.5 BodiTech Recent Development
13.14 Bristol-Myers Squibb Company
10.14.1 Bristol-Myers Squibb Company Company Details
10.14.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue
10.14.3 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Introduction
10.14.4 Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
10.14.5 Bristol-Myers Squibb Company Recent Development
13.15 GE Healthcare
10.15.1 GE Healthcare Company Details
10.15.2 GE Healthcare Business Overview and Its Total Revenue
10.15.3 GE Healthcare Prostate-specific Antigen (PSA) Testing Introduction
10.15.4 GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
10.15.5 GE Healthcare Recent Development
13.16 Endocare
10.16.1 Endocare Company Details
10.16.2 Endocare Business Overview and Its Total Revenue
10.16.3 Endocare Prostate-specific Antigen (PSA) Testing Introduction
10.16.4 Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
10.16.5 Endocare Recent Development
13.17 Merck&Co.
10.17.1 Merck&Co. Company Details
10.17.2 Merck&Co. Business Overview and Its Total Revenue
10.17.3 Merck&Co. Prostate-specific Antigen (PSA) Testing Introduction
10.17.4 Merck&Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
10.17.5 Merck&Co. Recent Development
13.18 Medtronic
10.18.1 Medtronic Company Details
10.18.2 Medtronic Business Overview and Its Total Revenue
10.18.3 Medtronic Prostate-specific Antigen (PSA) Testing Introduction
10.18.4 Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
10.18.5 Medtronic Recent Development
13.19 Sanofi-Aventis SA
10.19.1 Sanofi-Aventis SA Company Details
10.19.2 Sanofi-Aventis SA Business Overview and Its Total Revenue
10.19.3 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Introduction
10.19.4 Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
10.19.5 Sanofi-Aventis SA Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Prostate-specific Antigen (PSA) Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Prostate-specific Antigen (PSA) Testing Revenue
Table 3. Ranking of Global Top Prostate-specific Antigen (PSA) Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of CLIA Method
Table 6. Key Players of ELISA Method
Table 7. COVID-19 Impact Global Market: (Four Prostate-specific Antigen (PSA) Testing Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Prostate-specific Antigen (PSA) Testing Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Prostate-specific Antigen (PSA) Testing Players to Combat Covid-19 Impact
Table 12. Global Prostate-specific Antigen (PSA) Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Prostate-specific Antigen (PSA) Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Prostate-specific Antigen (PSA) Testing Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Prostate-specific Antigen (PSA) Testing Market Share by Regions (2015-2020)
Table 16. Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Prostate-specific Antigen (PSA) Testing Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Prostate-specific Antigen (PSA) Testing Market Growth Strategy
Table 22. Main Points Interviewed from Key Prostate-specific Antigen (PSA) Testing Players
Table 23. Global Prostate-specific Antigen (PSA) Testing Revenue by Players (2015-2020) (Million US$)
Table 24. Global Prostate-specific Antigen (PSA) Testing Market Share by Players (2015-2020)
Table 25. Global Top Prostate-specific Antigen (PSA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2019)
Table 26. Global Prostate-specific Antigen (PSA) Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Prostate-specific Antigen (PSA) Testing Product Solution and Service
Table 29. Date of Enter into Prostate-specific Antigen (PSA) Testing Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$)
Table 32. Global Prostate-specific Antigen (PSA) Testing Market Size Share by Type (2015-2020)
Table 33. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type (2021-2026)
Table 34. Global Prostate-specific Antigen (PSA) Testing Market Size Share by Application (2015-2020)
Table 35. Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$)
Table 36. Global Prostate-specific Antigen (PSA) Testing Market Size Share by Application (2021-2026)
Table 37. North America Key Players Prostate-specific Antigen (PSA) Testing Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Prostate-specific Antigen (PSA) Testing Market Share (2019-2020)
Table 39. North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$)
Table 40. North America Prostate-specific Antigen (PSA) Testing Market Share by Type (2015-2020)
Table 41. North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$)
Table 42. North America Prostate-specific Antigen (PSA) Testing Market Share by Application (2015-2020)
Table 43. Europe Key Players Prostate-specific Antigen (PSA) Testing Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Prostate-specific Antigen (PSA) Testing Market Share (2019-2020)
Table 45. Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Prostate-specific Antigen (PSA) Testing Market Share by Type (2015-2020)
Table 47. Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Prostate-specific Antigen (PSA) Testing Market Share by Application (2015-2020)
Table 49. China Key Players Prostate-specific Antigen (PSA) Testing Revenue (2019-2020) (Million US$)
Table 50. China Key Players Prostate-specific Antigen (PSA) Testing Market Share (2019-2020)
Table 51. China Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$)
Table 52. China Prostate-specific Antigen (PSA) Testing Market Share by Type (2015-2020)
Table 53. China Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$)
Table 54. China Prostate-specific Antigen (PSA) Testing Market Share by Application (2015-2020)
Table 55. Japan Key Players Prostate-specific Antigen (PSA) Testing Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Prostate-specific Antigen (PSA) Testing Market Share (2019-2020)
Table 57. Japan Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Prostate-specific Antigen (PSA) Testing Market Share by Type (2015-2020)
Table 59. Japan Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Prostate-specific Antigen (PSA) Testing Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Prostate-specific Antigen (PSA) Testing Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Prostate-specific Antigen (PSA) Testing Market Share (2019-2020)
Table 63. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Share by Type (2015-2020)
Table 65. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Share by Application (2015-2020)
Table 67. India Key Players Prostate-specific Antigen (PSA) Testing Revenue (2019-2020) (Million US$)
Table 68. India Key Players Prostate-specific Antigen (PSA) Testing Market Share (2019-2020)
Table 69. India Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$)
Table 70. India Prostate-specific Antigen (PSA) Testing Market Share by Type (2015-2020)
Table 71. India Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$)
Table 72. India Prostate-specific Antigen (PSA) Testing Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Prostate-specific Antigen (PSA) Testing Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Prostate-specific Antigen (PSA) Testing Market Share (2019-2020)
Table 75. Central & South America Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Prostate-specific Antigen (PSA) Testing Market Share by Type (2015-2020)
Table 77. Central & South America Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Prostate-specific Antigen (PSA) Testing Market Share by Application (2015-2020)
Table 79. Abbott Company Details
Table 80. Abbott Business Overview
Table 81. Abbott Product
Table 82. Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 83. Abbott Recent Development
Table 84. Boston Scientific Corporation Company Details
Table 85. Boston Scientific Corporation Business Overview
Table 86. Boston Scientific Corporation Product
Table 87. Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 88. Boston Scientific Corporation Recent Development
Table 89. Bayer AG Company Details
Table 90. Bayer AG Business Overview
Table 91. Bayer AG Product
Table 92. Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 93. Bayer AG Recent Development
Table 94. Siemens Healthcare Company Details
Table 95. Siemens Healthcare Business Overview
Table 96. Siemens Healthcare Product
Table 97. Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 98. Siemens Healthcare Recent Development
Table 99. DiaSorin Company Details
Table 100. DiaSorin Business Overview
Table 101. DiaSorin Product
Table 102. DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 103. DiaSorin Recent Development
Table 104. Roche Company Details
Table 105. Roche Business Overview
Table 106. Roche Product
Table 107. Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 108. Roche Recent Development
Table 109. Beckman Coulter Company Details
Table 110. Beckman Coulter Business Overview
Table 111. Beckman Coulter Product
Table 112. Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 113. Beckman Coulter Recent Development
Table 114. PerkinElmer Business Overview
Table 115. PerkinElmer Product
Table 116. PerkinElmer Company Details
Table 117. PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 118. PerkinElmer Recent Development
Table 119. Tosoh Company Details
Table 120. Tosoh Business Overview
Table 121. Tosoh Product
Table 122. Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 123. Tosoh Recent Development
Table 124. Ortho Clinical Company Details
Table 125. Ortho Clinical Business Overview
Table 126. Ortho Clinical Product
Table 127. Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 128. Ortho Clinical Recent Development
Table 129. Fujirebio Company Details
Table 130. Fujirebio Business Overview
Table 131. Fujirebio Product
Table 132. Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 133. Fujirebio Recent Development
Table 134. Mediwatch Company Details
Table 135. Mediwatch Business Overview
Table 136. Mediwatch Product
Table 137. Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 138. Mediwatch Recent Development
Table 139. BodiTech Company Details
Table 140. BodiTech Business Overview
Table 141. BodiTech Product
Table 142. BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 143. BodiTech Recent Development
Table 144. Bristol-Myers Squibb Company Company Details
Table 145. Bristol-Myers Squibb Company Business Overview
Table 146. Bristol-Myers Squibb Company Product
Table 147. Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 148. Bristol-Myers Squibb Company Recent Development
Table 149. GE Healthcare Company Details
Table 150. GE Healthcare Business Overview
Table 151. GE Healthcare Product
Table 152. GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 153. GE Healthcare Recent Development
Table 154. Endocare Company Details
Table 155. Endocare Business Overview
Table 156. Endocare Product
Table 157. Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 158. Endocare Recent Development
Table 159. Merck&Co. Company Details
Table 160. Merck&Co. Business Overview
Table 161. Merck&Co. Product
Table 162. Merck&Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 163. Merck&Co. Recent Development
Table 164. Medtronic Company Details
Table 165. Medtronic Business Overview
Table 166. Medtronic Product
Table 167. Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 168. Medtronic Recent Development
Table 169. Sanofi-Aventis SA Company Details
Table 170. Sanofi-Aventis SA Business Overview
Table 171. Sanofi-Aventis SA Product
Table 172. Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020) (Million US$)
Table 173. Sanofi-Aventis SA Recent Development
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate-specific Antigen (PSA) Testing Market Share by Type: 2020 VS 2026
Figure 2. CLIA Method Features
Figure 3. ELISA Method Features
Figure 4. Global Prostate-specific Antigen (PSA) Testing Market Share by Application: 2020 VS 2026
Figure 5. Screening Case Studies
Figure 6. Post-treatment Monitoring Case Studies
Figure 7. Other Case Studies
Figure 8. Prostate-specific Antigen (PSA) Testing Report Years Considered
Figure 9. Global Prostate-specific Antigen (PSA) Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Prostate-specific Antigen (PSA) Testing Market Share by Regions: 2020 VS 2026
Figure 11. Global Prostate-specific Antigen (PSA) Testing Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Prostate-specific Antigen (PSA) Testing Market Share by Players in 2019
Figure 14. Global Top Prostate-specific Antigen (PSA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Prostate-specific Antigen (PSA) Testing Revenue in 2019
Figure 16. North America Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Prostate-specific Antigen (PSA) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Abbott Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 25. Boston Scientific Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Boston Scientific Corporation Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 27. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Bayer AG Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 29. Siemens Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Siemens Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 31. DiaSorin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. DiaSorin Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 33. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Roche Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 35. Beckman Coulter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Beckman Coulter Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 37. PerkinElmer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. PerkinElmer Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 39. Tosoh Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Tosoh Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 41. Ortho Clinical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Ortho Clinical Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 43. Fujirebio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Fujirebio Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 45. Mediwatch Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Mediwatch Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 47. BodiTech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. BodiTech Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 49. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Bristol-Myers Squibb Company Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 51. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. GE Healthcare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 53. Endocare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Endocare Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 55. Merck&Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Merck&Co. Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 57. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Medtronic Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 59. Sanofi-Aventis SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Sanofi-Aventis SA Revenue Growth Rate in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs